Table 1 Clinical features of all Crohn's disease patients
Characteristics | Baseline (n = 49) |
|---|---|
Age at inclusion, years (mean ± SD) | 25.82 ± 9.90 |
Gender (male: female) | 3.9:1 |
Active smokers, n (%) | 10 (20.4) |
Scanning interval, months (median, IQR) | 4.5 (3.5, 7.5) |
Treatment, n (%) | |
Biological agents | 38 (77.6) |
Infliximab | 29 |
Adalimumab | 4 |
Vedolizumab | 3 |
Ustekinumab | 2 |
Enteral nutrition | 7 (14.3) |
Immunosuppressant + corticosteroid | 3 (6.1) |
5-ASA | 1 (2.0) |